Skip to content
healthcare.dev

Bromocriptine mesylate

NDC 0574-0106, Bromocriptine mesylate, tablet, from Padagis US LLC.

Product NDC
0574-0106
Status
Listed
Labeler
Padagis US LLC
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA077646
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/0574-0106 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • BROMOCRIPTINE MESYLATE2.5 mg/1

Pharmacologic classes

Ergolines [CS]; Ergot Derivative [EPC]

Package NDCNDC-11Package
0574-0106-0100574010601100 TABLET in 1 BOTTLE, PLASTIC (0574-0106-01)
0574-0106-030057401060330 TABLET in 1 BOTTLE, PLASTIC (0574-0106-03)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/0ee2da00-faf8-4c51-a696-9462fa4f6050
  • NADAC price for package 00574010601

    GET /v1/drugs/nadac/00574010601
  • NADAC price for package 00574010603

    GET /v1/drugs/nadac/00574010603

Use it

Look up 0574-0106 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/0574-0106 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 0574-0106. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.